Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps
    Research study

    Reaching semi-nomadic groups using a test and treat (with doxycycline) strategy in a challenging onchocerciasis focus in the west region of Cameroon

    On this page

    • Main objectives
    • Summary
    • Reports and resources
    On this page
    • Main objectives
    • Summary
    • Reports and resources

    Main objectives

    • To establish the effectiveness of mobile outreach with a doxycycline test and treat strategy (TnT) in reducing onchocerciasis prevalence and intensity of infection among hard-to-reach nomadic groups in the Massangam health area of Cameroon

    Summary

    Alternative treatment strategies (ATS) implemented in Massangam Health District (HD) including test and treat with doxycycline and ivermectin mass drug administration (MDA) could only reach 20% of the nomadic population considered to be at higher risk of infection and reservoir for transmission.

    As well as the implicit equity concerns with the exclusion of this group from both treatment strategies, there is a risk that they constitute a roaming reservoir of transmission and will impede elimination efforts. A recent qualitative assessment of the ATS in the Massangam health area (HA) revealed the barriers in reaching this hard-to-reach nomadic population.

    The barriers included remote, dispersed and small settlements, high mobility, communication barriers, CDD-linked challenges, limited information on them,  low awareness of mass drug administration and education/literacy rates.

    This study trialled and evaluated a mobile outreach strategy with test and treat with doxycycline, to better serve the semi-nomadic population. In doing so, it explored the movement and turnover of the population and also determined the level (rate) of onchocerciasis infection in them.

    Reports and resources

    Read the summary report (pdf)
    Research_Summary_SSI_nomad_FINAL

    Read the full report (pdf)
    Sightsavers_Nomad report_ FINAL

     

    Other resource
    Project: Alternative intervention strategies for accelerating onchocerciasis elimination

    Blog: Reaching nomadic communities during COVID-19

    ‘From the field’ article and video: Finding nomadic communities – our research in action

     

    Related tags

    Onchocerciasis
    Cameroon
    Study details
    Start date
    October 2019
    Finish date
    December 2021
    Main contact
    Rogers Nditanchou
    Regional Research Adviser
    rnditanchou@sightsavers.org
    Partners
    • Ministry of Health, Cameroon
    • Centre de Recherche sur les Filarioses Lymphatiques et autre Maladies Tropicales Négligés (CRFilMT)
    Funders
    The Task Force for Global Health
    Countries
    Cameroon
    Themes/conditions
    Onchocerciasis
    Study details
    Start date
    October 2019
    Finish date
    December 2021
    Main contact
    Rogers Nditanchou
    Regional Research Adviser
    rnditanchou@sightsavers.org
    Partners
    • Ministry of Health, Cameroon
    • Centre de Recherche sur les Filarioses Lymphatiques et autre Maladies Tropicales Négligés (CRFilMT)
    Funders
    The Task Force for Global Health
    Countries
    Cameroon
    Themes/conditions
    Onchocerciasis

    Related research studies

    Research study

    Qualitative assessment of implementation challenges for onchocerciasis programming in Sierra Leone

    Research study

    Investigation into community-directed treatment with ivermectin (CDTi) in Tano-Ankobra onchocerciasis transmission zone in Ghana

    Research study

    Evaluating whether the ivermectin mass drug administration stoppage threshold for onchocerciasis can be safely adjusted

    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.